Paeoniflorin inhibits MRGPRX2‐mediated pseudo‐allergic reaction via calcium signaling pathway

Mas‐related G protein‐coupled receptor‐X2 (MRGPRX2) expressed on mast cells (MCs) has been shown to be a pivotal target for pseudo‐allergic diseases. Therefore, MRGPRX2 might be a therapeutic target for allergic contact dermatitis, atopic dermatitis, and red man syndrome. Paeoniflorin (PF) was reported to have an antiinflammatory effect in neuroinflammation, enteritis, and so forth. In this study, we investigated the anti‐pseudo‐allergic effect of PF and the underlying molecular mechanisms. Our results showed that PF can suppress compound 48/80 (C48/80)‐induced PCA and MCs degranulation in vivo, in a dose‐dependent manner. Moreover, PF can reduce C48/80‐induced calcium influx and suppress MC degranulation and chemokines release in vitro. PF can downregulate the phosphorylation levels of key kinases in PLCγ‐regulated calcium influx and subsequent cytokine synthesis pathways. Our study revealed that PF could inhibit C48/80‐induced allergic responses both in vivo and in vitro. As such, it may be regarded as a novel inhibitor for preventing MRGPRX2‐mediated allergic diseases.

[1]  M. Furuno,et al.  Novel MRGPRX2 antagonists inhibit IgE‐independent activation of human umbilical cord blood‐derived mast cells , 2019, Journal of leukocyte biology.

[2]  Zhenyu Zhou,et al.  Paeoniflorin protects pancreatic &bgr; cells from STZ‐induced damage through inhibition of the p38 MAPK and JNK signaling pathways , 2019, European journal of pharmacology.

[3]  L. Kluwe,et al.  Paeoniflorin inhibits tributyltin chloride-induced apoptosis in hypothalamic neurons via inhibition of MKK4-JNK signaling pathway. , 2019, Journal of ethnopharmacology.

[4]  Xinzhong Dong,et al.  Activation of Mast-Cell-Expressed Mas-Related G-Protein-Coupled Receptors Drives Non-histaminergic Itch. , 2019, Immunity.

[5]  Tao Zhang,et al.  Dehydroandrographolide inhibits IgE‐mediated anaphylactic reactions via calcium signaling pathway , 2019, Toxicology and applied pharmacology.

[6]  R. Xu,et al.  Paeoniflorin Inhibits Hepatocyte Growth Factor- (HGF-) Induced Migration and Invasion and Actin Rearrangement via Suppression of c-Met-Mediated RhoA/ROCK Signaling in Glioblastoma , 2019, BioMed research international.

[7]  Rui Liu,et al.  Mivacurium induce mast cell activation and pseudo-allergic reactions via MAS-related G protein coupled receptor-X2. , 2018, Cellular immunology.

[8]  Yingnan Zeng,et al.  Anti-pseudo-allergy effect of isoliquiritigenin is MRGPRX2-dependent. , 2018, Immunology letters.

[9]  D. Cen,et al.  Paeoniflorin inhibits the growth of bladder carcinoma via deactivation of STAT3 , 2018, Acta pharmaceutica.

[10]  Yongshuai Jiang,et al.  Paeoniflorin ameliorates collagen‐induced arthritis via suppressing nuclear factor‐κB signalling pathway in osteoclast differentiation , 2018, Immunology.

[11]  Xinzhong Dong,et al.  Saikosaponin A inhibits compound 48/80‐induced pseudo‐allergy via the Mrgprx2 pathway in vitro and in vivo , 2018, Biochemical pharmacology.

[12]  Mingjun Xie,et al.  Paeoniflorin Ameliorates Atherosclerosis by Suppressing TLR4-Mediated NF-κB Activation , 2017, Inflammation.

[13]  Xinzhong Dong,et al.  Typical antimicrobials induce mast cell degranulation and anaphylactoid reactions via MRGPRX2 and its murine homologue MRGPRB2 , 2017, European journal of immunology.

[14]  H. Subramanian,et al.  Differential Regulation of Mas-Related G Protein-Coupled Receptor X2-Mediated Mast Cell Degranulation by Antimicrobial Host Defense Peptides and Porphyromonas gingivalis Lipopolysaccharide , 2017, Infection and Immunity.

[15]  Yuchi Zhang,et al.  Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease , 2017, Neuropharmacology.

[16]  E. Lerner,et al.  MRGPRX2, atopic dermatitis, and red man syndrome , 2017, Itch (Philadelphia, Pa.).

[17]  Jing Liu,et al.  In silico design of novel probes for the atypical opioid receptor MRGPRX2 , 2016, Nature chemical biology.

[18]  Xinzhong Dong,et al.  Different activation signals induce distinct mast cell degranulation strategies. , 2016, The Journal of clinical investigation.

[19]  H. Subramanian,et al.  Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases. , 2016, The Journal of allergy and clinical immunology.

[20]  Xinzhong Dong,et al.  Identification of a mast cell specific receptor crucial for pseudo-allergic drug reactions , 2014, Nature.

[21]  P. Bryce,et al.  IgE-mediated mast cell responses are inhibited by thymol-mediated, activation-induced cell death in skin inflammation. , 2014, The Journal of allergy and clinical immunology.

[22]  J. Blic,et al.  Anaphylaxis during anesthesia: results of a 12‐year survey at a French pediatric center , 2005, Allergy.